Mathias Schenk

Statistics

Publications

Citations

164

H-Index

Active since

2020

Affiliations

Fraunhofer Institute for Cell Therapy and Immunology(Current)

Anhalt University of Applied Sciences

Leipzig University

Harvard University

Brigham and Women's Hospital

Mathias Schenk is an author at Fraunhofer Institute for Cell Therapy and Immunology specializing in amyloid beta-targeted therapy, alzheimer disease, and neuroscience.

ORCID

Publications per year

2020–2024

Publications

Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells

Tao Sun, Qiaoqiao Shi, Yongzhi Zhang et al. · Journal of Controlled Release · 2021 · 38 citations · Full text

Life Sciences, Immunology, Neuroscience +15

A glutaminyl cyclase-catalyzed α-synuclein modification identified in human synucleinopathies

Maike Hartlage‐Rübsamen, Alexandra Bluhm, Sandra Moceri et al. · Acta Neuropathologica · 2021 · 29 citations · Full text

Life Sciences, Biochemistry, Neuroscience +17

Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer’s disease-like pathology

Kathrin Gnoth, Anke Piechotta, Martin Kleinschmidt et al. · Alzheimer s Research & Therapy · 2020 · 22 citations · Full text

Pharmacy, Biotechnology, Pharmacology +17

Electrostatic anti-CD33-antibody–protamine nanocarriers as platform for a targeted treatment of acute myeloid leukemia

Nicole Bäumer, Annika Scheller, Lisa Wittmann et al. · Journal of Hematology & Oncology · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacology +15

Acute Effects of Focused Ultrasound-Induced Blood-Brain Barrier Opening on Anti-Pyroglu3 Abeta Antibody Delivery and Immune Responses

Praveen Bathini, Tao Sun, Mathias Schenk et al. · Biomolecules · 2022 · 20 citations · Full text

Pharmacy, Neurobiology, Neuroscience +17

1–5 of 7